Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

Completed · Phase 3

Conditions studied: Hay Fever, Perennial Allergic Rhinitis

In brief

The purpose of this study is to evaluate the safety and tolerability of ciclesonide nasal spray for long term use in relieving symptoms in perennial allergic rhinitis.

Key facts

Study ID

NCT00261287

Run by

AstraZeneca

People needed

102

Starts

2005-11-01

Expected to finish

2006-06-01

Last updated by the study team

2016-11-30

Who can join

Age: 2 and older, up to 5. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Altana Pharma/Nycomed — Long Beach, California, United States
• Altana Pharma/Nycomed — Normal, Illinois, United States
• Altana Pharma/Nycomed — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.